BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16788921)

  • 1. Photodynamic therapy and anti-tumor immunity.
    Gollnick SO; Owczarczak B; Maier P
    Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 monoclonal antibody activation of antigen-presenting cells improves therapeutic efficacy of tumor-specific T cells.
    Bergstrom RT; Silverman DA; Chambers K; Kim JA
    Otolaryngol Head Neck Surg; 2004 Jan; 130(1):94-103. PubMed ID: 14726917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
    Korbelik M; Dougherty GJ
    Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy.
    Hendrzak-Henion JA; Knisely TL; Cincotta L; Cincotta E; Cincotta AH
    Photochem Photobiol; 1999 May; 69(5):575-81. PubMed ID: 10333764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
    Korbelik M; Krosl G; Krosl J; Dougherty GJ
    Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
    Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S
    Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
    J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
    O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
    J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
    deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
    Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
    Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy boosts anti-glioma immunity in mice: a dependence on the activities of T cells and complement C3.
    Li F; Cheng Y; Lu J; Hu R; Wan Q; Feng H
    J Cell Biochem; 2011 Oct; 112(10):3035-43. PubMed ID: 21678475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
    Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
    Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.